NEW YORK (GenomeWeb) – The Jackson Laboratory announced today that it is trying to reach a collaborative clinical genomics research agreement with groups in Wenzhou, China.

The lab is aiming to partner with the Wenzhou Municipal People's Government, Ouhai District People's Government, and Wenzhou Medical University and its affiliated hospitals, in order to conduct research on genomic propensities for disease. The collaboration will also focus on the development of individualized therapies for cancer, heart disease, and other afflictions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.

Sponsored by
Ion Torrent

This webinar will discuss how next-generation sequencing (NGS) can help clinical research labs and pathologists save time, money, and samples compared to single-analyte oncology research assays.